Workflow
IDEX(IEX)
icon
Search documents
IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year
ZACKS· 2024-10-30 11:46
IDEX Corporation's (IEX) third-quarter 2024 adjusted earnings of $1.90 per share surpassed the Zacks Consensus Estimate of $1.89. The bottom line decreased approximately 10.4% from the year-ago quarter's earnings of $2.12. However, it matched the upper band of the management's projected range of $1.85-$1.90 per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. IEX's Revenue Details IDEX's net sales of $798.2 million beat the Zacks Consensus Estimate of $791 million. The top li ...
Idex (IEX) Reports Q3 Earnings: What Key Metrics Have to Say
ZACKS· 2024-10-29 23:01
For the quarter ended September 2024, Idex (IEX) reported revenue of $798.2 million, up 0.6% over the same period last year. EPS came in at $1.90, compared to $2.12 in the year-ago quarter. The reported revenue represents a surprise of +0.92% over the Zacks Consensus Estimate of $790.95 million. With the consensus EPS estimate being $1.89, the EPS surprise was +0.53%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...
Idex (IEX) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2024-10-29 22:41
Company Performance - Idex reported quarterly earnings of $1.90 per share, exceeding the Zacks Consensus Estimate of $1.89 per share, but down from $2.12 per share a year ago, representing an earnings surprise of 0.53% [1] - The company posted revenues of $798.2 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.92% and showing an increase from $793.4 million year-over-year [2] - Over the last four quarters, Idex has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Future Outlook - The current consensus EPS estimate for the coming quarter is $2.03 on revenues of $849.16 million, and for the current fiscal year, it is $7.88 on revenues of $3.25 billion [7] - The estimate revisions trend for Idex is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Manufacturing - General Industrial industry, to which Idex belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Idex's stock performance [5]
IDEX Biometrics interim report for the third quarter of 2024
GlobeNewswire News Room· 2024-10-29 07:00
Oslo, Norway – 29 October 2024 - IDEX Biometrics ASA’s interim report for the third quarter is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Catharina Eklof, Chief Executive Officer, today at 09:00 CET. The webcast presentation is attached to this notice (link below), and can be viewed at the following link: https://idexbiometrics.video ...
IDEX Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
ZACKS· 2024-10-28 14:31
IDEX Corporation (IEX) is scheduled to release third-quarter 2024 results on Oct. 29, after market close. The Zacks Consensus Estimate for earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 5.9%. The consensus estimate for revenues is pegged at $791 million, indicating a decline of 0.3% from the prior-year quarter's figure. The consensus estima ...
Registration of share capital increase in IDEX Biometrics 14 Oct 2024
GlobeNewswire News Room· 2024-10-14 16:09
Group 1 - The private placement completed on 16 September 2024 raised total gross proceeds of NOK 70 million [1] - The share capital increase related to the Tranche 2 shares has been registered, resulting in a new share capital of NOK 120,812,483.10 divided into 805,416,554 shares, each with a nominal value of NOK 0.15 [2] - Tranche 2 shares will be delivered on a separate and non-tradable ISIN, pending the publication of an approved prospectus by the Norwegian Financial Supervisory Authority [2] Group 2 - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [3] - IDEX Biometrics partners with leading card manufacturers and technology companies to bring its solutions to market [3]
IDEX Biometrics ASA's extraordinary general meeting held on 9 October 2024
GlobeNewswire News Room· 2024-10-09 13:03
IDEX Biometrics ASA held an extraordinary general meeting on 9 October 2024. 112.2 million shares or 25.47% of the share capital was represented at the meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company's board of directors, including the approval of Tranche 2 of the private placement, the subsequent offering and the warrants issuance, all as announced on 17 September 2024. For further information contact: Marianne Bøe, Head of Investor Relations E-mail: ir@ide ...
Registration of share capital increase in IDEX Biometrics 26 Sep 2024
GlobeNewswire News Room· 2024-09-26 09:45
Reference is made to the notice on 25 September 2024 regarding issue of Tranche 1 shares of the private placement completed on 16 September 2024. The private placement consisted of two tranches, with total gross proceeds amounting to NOK 70 million. The share capital increase related to the Tranche 1 shares has been registered and the shares will be delivered soonest. The Tranche 1 shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of a prospectus approved by th ...
Issue of Tranche 1 shares in IDEX Biometrics private placement on 16 September 2024
GlobeNewswire News Room· 2024-09-25 11:16
Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 17 September 2024 regarding the private placement of shares with gross proceeds of NOK 70 million (the "Private Placement"). The Company retained Arctic Securities AS as sole manager and bookrunner for the Private Placement (the "Manager"). The Private Placement is divided into two tranches. 101,624,966 shares were allocated in the first tranche ("Tranche 1" and the "Tranche 1 Offer Shares") and 365,041,700 Offer Shares were all ...
IDEX Biometrics extraordinary general meeting held on 23 Sep 2024
GlobeNewswire News Room· 2024-09-23 11:35
IDEX Biometrics ASA held an extraordinary general meeting on 23 September 2024. 87.2 million shares or 25.7% of the share capital was represented at the meeting. The authorisation to the board to issue new shares, was approved by the extraordinary general meeting. The board will apply this authorization to issue the Tranche 1 Shares as disclosed in connection with the private placement on 16 September 2024: https://newsweb.oslobors.no/message/627919 . For the avoidance of doubt, the issue of Tranche 2 Share ...